Since![](fx1.gif) the last issue of the *Clinics in Chest Medicine* devoted to the topic of pneumonia, many significant advances have occurred in our understanding of the pathogenesis of respiratory infections, the microorganisms associated with pneumonia, and the prevention and treatment of this serious infection. One of the most important changes has been the escalation of bacterial resistance to currently available antimicrobial agents. Increasing rates of resistance have been observed in both community-associated and hospital-associated pneumonia. The changing patterns of antimicrobial resistance have made it more challenging for clinicians to provide initial appropriate antimicrobial treatment to patients with pneumonia. Additionally, it has become well established that delays in administering appropriate initial antibiotic treatment to patients with pneumonia is associated with greater risk of mortality.

New pathogens are also now recognized to be important etiologic agents of pneumonia, including community-associated, methicillin-resistant *Staphylococcus aureus*, the severe acute respiratory syndrome virus, and the human metapneumovirus. Additionally, public health concerns over the emergence of avian influenza and potential biologic threats with agents such as anthrax have resulted in greater public awareness of serious respiratory infections. The availability of novel immunosuppressive agents (eg, etanercept, infliximab) have also resulted in new patient populations being at risk for serious lung infections with fungal and mycobacterial pathogens. The changes in our understanding of pneumonia have necessitated the development of new guidelines for the management of this infection. The American Thoracic Society and the Infectious Disease Society of America will publish a joint guideline on the management of hospital-associated pneumonia in 2005. This will be followed by a joint guideline on the management of community-associated pneumonia at a later point in time.

This issue features reviews on the pathogenesis of pneumonia with emphasis on the host\'s inflammatory response to lung infection. Recommendations for the appropriate treatment of the various etiologic agents associated with pneumonia are also provided. Important articles discussing the various diagnostic approaches and prevention strategies for pneumonia are included to assist clinicians with their day-to-day management of patients. Although not all-encompassing, it is hoped that this issue will be a valuable tool providing an updated review on the topic of serious pneumonia requiring hospitalization. The rapid evolution of the etiologic agents associated with pneumonia, their antimicrobial susceptibilities, and advances in treatment require that clinicians caring for such patients stay current in this important field.
